{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011729","form_type":"8-K","ticker":"NVNO","cik":"0001661053","company_name":"enVVeno Medical Corp","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.244625+00:00","generated_at":"2026-05-21T00:09:18.260270+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"enVVeno Medical appoints Jennifer Bright as CFO, replacing Craig Glynn","bullets":["Craig Glynn resigned as CFO effective May 19, 2025; will serve as consultant for transition.","Jennifer Bright appointed CFO; 25+ yr CPA, ex-CFO of BIOLASE, salary $300K, bonus up to 40%.","Bright awarded 350,000 stock options at $3.62/share, vesting over 3 years with 1-year cliff.","No disagreement with Glynn; standard employment and indemnification agreements signed."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011729","json":"https://secwatch.observer/filing/0001641172-25-011729.json","markdown":"https://secwatch.observer/filing/0001641172-25-011729.md","text":"https://secwatch.observer/filing/0001641172-25-011729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T00:09:18.260270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1243d2cad4","claim":"Jennifer Bright was appointed as Chief Financial Officer at enVVeno Medical Corp.","evidence_excerpt":"On May 19, 2025, the Board of Directors (the “ Board ”) of enVVeno Medical Corporation (the “ Company ”) appointed Jennifer Bright as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"5833ac6194","claim":"Craig Glynn resigned as Chief Financial Officer at enVVeno Medical Corp.","evidence_excerpt":"On May 19, 2025, Craig Glynn resigned as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}